Companies Dominating the Age-related Macular Degeneration Landscape
- DaVinci, Magnifying America
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Freedom Scientific
- LVI Low Vision International
- NuEyes
- Canadian Assistive Technologies
- Merlin Ultra
- HumanWare
- Biogen
- Samsung Bioepis
- Eschenbach Optik GmbH
Browse Key Market Insights with Data Illustration:
In the News
- Mosaic Biosciences and Ocular Therapeutix entered into a investigate collaboration for the advancement of a medicate to treat patients with dry age-related macular degeneration. This collaboration fortifies the company's R&D portfolio and offers a tall development opportunity for the company.
- Aldeyra Therapeutics announced the advancement of its RASP modulator platform, including the anticipated submission of an IND application for the investigational RASP modulator ADX248 for the Phase ADX629 1/2 clinical trial in patients with dry form of age-related macular degeneration and dark adaptation deficit.
